Straumann Holding AG · SIX:STMN
Straumann — IDS 2005
39 slides from Straumann's conference presentation, Apr 12, 2005
Slide 1: Straumann 2005: Continuous innovation with proven clinical benefits
Straumann 2005 Continuous innovation with proven clinical benefits Gilbert Achermann Chief Executive Officer IDS, 12 April 2005
Slide 2: Table of contents
Table of contents 1. Straumann – a company snapshot 2. The implant dentistry market 3. Market trends 4. The Straumann portfolio 5. New products 2
Slide 3: Straumann – company snapshot
Straumann – company snapshot • Founded in 1954 • Global headquarters in Basel, Switzerland • Focused on: – Implant dentistry – Dental tissue regeneration • International Team of Implantology (ITI) as scientific partner • No. 2 globally, No. 1 in Europe and Asia, No. 2 in US • Over 1100 employees wor
Slide 4: World-wide presence
World-wide presence Straumann products and services are available in over 60 countries through 15 sales and marketing subsidiaries and a broad network of distributors 4
Slide 5: Straumann - the innovator in implant dentistry
Straumann - the innovator in implant dentistry 1974 Straumann® Dental Implant System pioneers the one-stage surgical procedure, the rough implant surface and an implant design that respects biologic width. 1986 Straumann introduces the morse taper connection, which is widely used in the industry tod
Slide 6: Sharp strategic focus
Sharp strategic focus Dental products Dental Implants Crown Other Other tissue & implant & bridge dental medical regeneration prosthetics materials products devices Straumann Nobel Biocare Biomet /3i Zimmer Dentsply 6
Slide 7: Our scientific partner ITI
Our scientific partner ITI* • ITI consensus guidelines for dental implant therapy published including application techniques for the Straumann® Dental Implant System • Revised cooperation agreement - Reorganization of the ITI with new country sections and member categories - ITI network accessible t
Slide 8: Table of contents
Table of contents 1. Straumann – a company snapshot 2. The implant dentistry market 3. Market trends 4. The Straumann portfolio 5. New products 8
Slide 9: Market size
Market size Global medical device market (100% in 2004 = USD 80 – 90 bn) Other Hearing Aids Global dental device market 7% Cardio- Diagnostics 4% (100% in 2004 = USD 5.5 – 6.6 bn) vascular 7% 38% Diabetes 9% Other (e.g. instruments, membranes, 9% growth factors) Ophthal- 22% mology 7% 17% Dental Pro
Slide 10: Continued attractive industry growth
Continued attractive industry growth Global implant dentistry & dental tissue regeneration market in CHF billion Straumann 01-04 CAGR 20% CAGR >15% 3.2 CAGR 15-17% 2.1 1.8 Tissue regeneration 1.5 1.3 Implant dentistry 2001 2002 2003 2004 2007 Source: Straumann estimates CAGR: Compounded annual growt
Slide 11: Penetration of implant-based treatment
Penetration of implant-based treatment Treatment forms as % of all tooth replacements performed Treatment form Implant-based ~10%* Reasons for low penetration: • Implant dentistry not part of standard dentist curriculum Conventional • Generally, no insurance coverage (crown & bridge) ~90%* (conventi
Slide 12: Table of contents
Table of contents 1. Straumann – a company snapshot 2. The implant dentistry market 3. Market trends 4. The Straumann portfolio 5. New products 12
Slide 13: Market trends
Market trends Wolfgang Becker Executive Vice President Germany
Slide 14: Drivers for implant dentistry
Drivers for implant dentistry Demographics • Aging population and increasing • Increasing wealth (implant treatment not reimbursed*) wealth • Awareness of benefits of implants over conventional Growing patient solutions awareness • Increasing importance of esthetics Increasing • Long-term clinical s
Slide 15: Trends in implant dentistry
Trends in implant dentistry Increasing • Easy handling of system importance of • Documented long-term safety and clinical benefit general dentists • Access to training and support • Surgical protocols reducing number and duration Faster of treatment sessions “time-to-teeth” • Surface modification to
Slide 16: Reimbursement (general)
Reimbursement (general) • As a rule, implant-borne restorations are not reimbursed by state healthcare schemes unless tooth loss is due to trauma. Exceptions: Conventional treatment Implant-based restorations Netherlands Not reimbursed Full reimbursement for edentulous patients (currently Sweden 15%
Slide 17: Reimbursement in Germany
Reimbursement in Germany • Changes in dental coverage by the statutary health insurance • New ruling includes fixed subsidy for implant-borne tooth replacement, putting it on the same level as conventional tooth replacement • Positive effect on implant-borne treatment in the long term 17 E004
Slide 18: Reimbursement in Germany
Reimbursement in Germany 0 200 400 600 800 1.000 1.200 1.400 Details 1 bridge for single tooth gap: 275 € to 515 € 1 bridge 275 (model cast without bonus, or bridge with 30% single tooth gap 515 bonus and 3 veneers) 1 bridge 275 1 bridge for two missing teeth: 275 € to 620 € 2 missing teeth (model c
Slide 19: Table of contents
Table of contents 1. Straumann – a company snapshot 2. The implant dentistry market 3. Market trends 4. The Straumann portfolio 5. New products 19
Slide 20: Product overview
Product overview Dr Sandro Matter Executive Vice President Products
Slide 21: Product concept of the Straumann Dental Implant System
Product concept of the Straumann® Dental Implant System • Implants designed for optimal tissue response Reliable • Reduced healing time thanks to SLA® surface • Morse taper connection for maximum stability • One system – one concept Simple • Logical component structure • Procedures that are easy to
Slide 22: An implant portfolio for all indications...
An implant portfolio for all indications... Narrow Standard Standard Wide Tapered Mono Neck Plus Neck Effect Type Lateral Transgingival Semi-/submerged Molars Immediate Edentulous incisors, lower (one-stage) placement for implantation mandible middle incisors procedure esthetic indications 22
Slide 23: ... and a comprehensive prosthetics range
... and a comprehensive prosthetics range Screw-retained Screw-retained Cemented Cementedrestorations restorations restorations* restorations* RN RN WN RN WN RN WN synOcta ® synOcta®prosthetic prostheticsystem system Solid Solidabutment abutment *Examples RN = Regular Neck / WN = Wide Neck 23
Slide 24: Other products (illustrative)
Other products (illustrative) Impression Impressiontaking takingand and Instrumentation Instrumentation Post Postsurgery surgery prosthetic restoration prosthetic restoration + 24
Slide 25: Implants complemented by biologics
Implants complemented by biologics Tooth Toothpreservation preservation Tooth Toothreplacement replacement Periodontal Same Tissue regeneration tissue technology using guided bone regeneration platform regeneration (GBR) Natural Implant tooth 25
Slide 26: Periodontal tissue regeneration with Emdogain
Periodontal tissue regeneration with Emdogain® • Protein-based technology • Promotes predictable re-growth of hard and soft tissues lost due to periodontal disease and thereby regenerates new tooth supporting tissues • Enhanced wound healing, increased patient comfort • Over 100 scientific publicati
Slide 27: Table of contents
Table of contents 1. Straumann – a company snapshot 2. The implant dentistry market 3. Market trends 4. The Straumann portfolio 5. New products 27
Slide 28: Introducing Straumann CARES, a new individualised abutment service
Introducing Straumann® CARES, a new individualised abutment service Video trailer 28
Slide 29: Straumann CARES: individualised abutments with Straumann precision
Straumann® CARES: individualised abutments with Straumann precision Dentist Dental lab Straumann Impression 3D scanning Computer-aided Ordering Manufacture design Shipping Finishing 29
Slide 30: Risks of mixing systems
Risks of mixing systems Competitor titanium abutment compared with Straumann titanium meso abutment, both screwed on to Straumann Regular Neck implants at a torque of 35 Ncm. Competitor titanium abutment Straumann titanium meso abutment 30
Slide 31: Competitor ceramic abutment on Straumann dental implant
Competitor ceramic abutment on Straumann dental implant • Unsatisfactory gap • Increased risk of: • Abutment not centred – breakage due to unstable prosthetic – screw loosening – bacteria build-up in the gap – implant loss due to infection 31
Slide 32: RN synOcta Gold Abutment – added flexibility for optimal esthetic results
RN synOcta® Gold Abutment – added flexibility for optimal esthetic results • One-piece design - fewer components - single submerged fixing screw - greater flexibility for final restoration, especially in esthetic region, due to screw being submerged deeper • Direct cast-on possible - ideal for custo
Slide 33: Straumann Bone Block Fixation Set
Straumann® Bone Block Fixation Set Comprises precision instruments and hardware for fixing bone graft block to dental implant site, including: • Drills • Various screws • Screw holding device and driver • Multipurpose cassette for sterilizing and storage 33
Slide 34: Straumann Single Patient Drills
Straumann® Single Patient Drills • Convenient handling • Ready sterilized • Special integral handling piece for transfer to sterile area without contamination • Same dimensions, cutting geometry and depth markings as repeated-use drills • Color-coded to simplify surgical sequence • Globally availabl
Slide 35: SLActive – taking surface technology a step further
SLActive – taking surface technology a step further • Pre-clinical results in 2004 Statistically significant: - Enhanced cell-response to SLActive - Increased bone-to-implant contact - improvement in early osseointegration • Clinical trials in progress - Multi-center study with 21 clinics - Two addi
Slide 36: Straumann Bone Ceramic
Straumann® Bone Ceramic • Fully synthetic bone-graft substitute • CE mark and FDA clearance • Benefits - Unique wetting and surgical handling properties - Optimal degradability - Approved for broad indication • Controlled market introduction (started Q4 2004) • Product surveillance ongoing (10 count
Slide 37: Outlook Products
Outlook Products • Straumann will continue to optimize its range of products and services with meaningful innovations. • We shall also remain true to our philosophy of introducing products that offer both clear benefits to customers and clinical advantages. • We shall continue adapting the product r
Slide 38: Questions & Answers
Z straumann Questions & Answers 38
Slide 39: Disclaimer
Disclaimer This presentation contains certain “forward-looking statements”, which can be identified by use of terminology such as “will”, “expect”, “intend”, “continue”, “achieve”, “maintain”, “improve”, “foresee”, “product introductions”, “outlook”, “forecast”, or similar wording. Such forward-look